Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Study

Purpose

The purpose of this study is to learn about the experiences of cancer patients during treatment utilizing a mobile app called EveryDose© to track prescribed oral treatment for cancer. Based on these experiences, the study team will decide on expanding this pilot study to evaluate other methods that may prove to be beneficial in supporting cancer patient's ability to take cancer medications as prescribed (another common phrase used for this is adherence to treatment).

Condition

  • Cancer

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Any sex/gender Able to provide written informed consent - Able to read/understand English or Spanish - Diagnosis of hematologic or solid tumor cancer diagnosis - Prescribed an oral anti-cancer drug as monotherapy treatment for the first time by their treating oncologist. - Internet access on a smartphone, tablet, or computer

Exclusion Criteria

  • Less than 18 years of age - Unable to provide written informed consent - Unable to read/understand English or Spanish - History of dementia or major psychiatric disease that would interfere with study participation - Prior treatment with an oral anti-cancer treatment - Participating in another clinical trial during the time of screening.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Supportive Care
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
EveryDose Mobile Application Group
Participants in this group will use the EveryDose mobile application for up to 12 weeks.
  • Behavioral: EveryDose Mobile Application
    Participants will use this application every day for up to 10 minutes, for up to 12 weeks. The purpose of the application is to improve medication adherence. Participants will receive an alert to the mobile device while at home to ensure medication was taken, and to serve as a medication log.

Recruiting Locations

University of Miami
Miami, Florida 33136
Contact:
Aaron Riffa, BSN
305-243-5716
aaronriffa@med.miami.edu

More Details

Status
Recruiting
Sponsor
University of Miami

Study Contact

Jessica MacIntyre, DNP
305-243-4570
jmacintyre@med.miami.edu